Skip to main content

Leads

Renae Boerneke, PharmD, BCPS, CPP and Mildred Kwan, MD PhD

Project Manager

Matt Huemmer, MBA, MHA, CLSSGB, CLSSBB

Aim

Global

Increase use of appropriate, targeted antibiotics for specific infections in patients with a PCN allergy label.

SMART Aim

1. Assess 100 (ID Clinic, 50 patients non-ID Clinic providers) patients with PCN Assessment in ID clinic by July 2021. (Concrete goal)

2. 20% of assessed patients in ID clinic delabeled overall

2021 IHQI Symposium Presentation Slides